Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Market Capitalization (2014 - 2026)

Scynexis' (SCYX) quarterly Market Capitalization came in at $40.5 million in Q2 2026, up 20.64% on a YoY basis from $33.6 million in Q2 2025, and down 13.33% quarter-over-quarter from $46.7 million in Q1 2026.

Analysis

Scynexis (SCYX) Market Capitalization (2014 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Market Capitalization for 13 consecutive years, with $40.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Market Capitalization rose 20.64% year-over-year to $40.5 million; the trailing twelve-month figure through Jun 2026 stood at $40.5 million (up 20.64% YoY), and the FY2025 full-year result was $27.5 million, down 53.09% from the prior year.
  • Market Capitalization eased to $40.5 million in Q2 2026 per SCYX's latest filing, from $46.7 million in the prior quarter.
  • Across five years, Market Capitalization topped out at $143.3 million in Q1 2023 and bottomed at $27.5 million in Q4 2025.
  • Historically, Market Capitalization has averaged $77.9 million across 5 years, with a median of $71.7 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Market Capitalization soared 75.28% in 2023, then tumbled 65.4% in 2025.
  • Over 5 years, Market Capitalization stood at $66.5 million in 2022, then surged by 60.52% to $106.7 million in 2023, then tumbled by 44.99% to $58.7 million in 2024, then sank by 53.09% to $27.5 million in 2025, then soared by 47.07% to $40.5 million in 2026.
  • According to Business Quant data, Market Capitalization over the past three periods registered $40.5 million, $46.7 million, and $27.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.49 Mn
Mar 31, 2026 46.72 Mn
Dec 31, 2025 27.53 Mn
Sep 30, 2025 32.31 Mn
Jun 30, 2025 33.57 Mn
Mar 31, 2025 47.07 Mn
Dec 31, 2024 58.70 Mn
Sep 30, 2024 72.44 Mn
Jun 30, 2024 97.02 Mn
Mar 31, 2024 70.92 Mn
Dec 31, 2023 106.71 Mn
Sep 30, 2023 109.19 Mn
Jun 30, 2023 141.12 Mn
Mar 31, 2023 143.27 Mn
Dec 31, 2022 66.48 Mn
Sep 30, 2022 114.01 Mn
Jun 30, 2022 80.51 Mn
Mar 31, 2022 114.25 Mn
Dec 31, 2021 175.10 Mn
Sep 30, 2021 126.59 Mn